Cubist Pharmaceuticals (Nasdaq: CBST) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.
Recent Mentions on Fool.com
- Cubist and Durata Heat Up Antibiotic Market
- This is the 1 Thing AstraZeneca Should Do to Improve Shareholder Value
- What's Next for Cubist Pharmaceuticals Inc. and Durata Therapeutics, Inc.?
- 3 Upcoming FDA Meetings You Should be Watching
- Better Buy: Cubist Pharmaceuticals, Inc. vs. Durata Therapeutics, Inc.